Interestingly, BAFF but not APRIL was critical for CLL initiation and progression, as TCL1-Tg BAFF-/- mice had reduced frequency and absolute numbers of CD5+CD19+ CLL cells in the blood (Figure 2A; Supplementary Figure 1A). The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.